IL1B and Behcet disease: In steatotic grafts, suppression of NO (BD+NAME+LT) reduced hepatic IL-10 and worsened hepatic damage and inflammation in comparison to the BD+LT group; all of this was associated with more elevated IL-1β levels than those in the BD+LT group (Figures 8–10).